CA2516652A1 - Systeme pour la commande externe de la reproduction d'un virus oncolytique - Google Patents
Systeme pour la commande externe de la reproduction d'un virus oncolytique Download PDFInfo
- Publication number
- CA2516652A1 CA2516652A1 CA002516652A CA2516652A CA2516652A1 CA 2516652 A1 CA2516652 A1 CA 2516652A1 CA 002516652 A CA002516652 A CA 002516652A CA 2516652 A CA2516652 A CA 2516652A CA 2516652 A1 CA2516652 A1 CA 2516652A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- cell
- transcriptional
- adenovirus
- adenovirus vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45023203P | 2003-02-24 | 2003-02-24 | |
US60/450,232 | 2003-02-24 | ||
PCT/US2004/005518 WO2005007832A2 (fr) | 2003-02-24 | 2004-02-24 | Systeme pour la commande externe de la reproduction d'un virus oncolytique |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2516652A1 true CA2516652A1 (fr) | 2005-01-27 |
Family
ID=34078982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002516652A Abandoned CA2516652A1 (fr) | 2003-02-24 | 2004-02-24 | Systeme pour la commande externe de la reproduction d'un virus oncolytique |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1597354A4 (fr) |
JP (1) | JP2007500012A (fr) |
CA (1) | CA2516652A1 (fr) |
WO (1) | WO2005007832A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1900749A1 (fr) * | 2006-09-12 | 2008-03-19 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Acide nucléique pour l'expression d'un polynucléotide d'interêt dans des cellules cancéreuses de mammiferès |
EE05711B1 (et) * | 2009-10-07 | 2014-04-15 | Tartu Ülikool | Meetod ja kompositsioon konditsionaalselt letaalsete viirusmutantide loomiseks ja eukarootse raku elulisuse k?rvaldamiseks |
CN101899420A (zh) * | 2010-01-16 | 2010-12-01 | 韩从辉 | 一种靶向抗前列腺肿瘤的表达超抗原基因的双调控溶瘤腺病毒的制备方法 |
CN114561430B (zh) * | 2022-03-25 | 2024-03-26 | 新乡医学院 | 人源化细胞瞬时表达用表达载体、表达系统、构建方法及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197293B1 (en) * | 1997-03-03 | 2001-03-06 | Calydon, Inc. | Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
AU744725B2 (en) * | 1997-03-03 | 2002-02-28 | Cold Genesys, Inc. | Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
US6692736B2 (en) * | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
-
2004
- 2004-02-24 CA CA002516652A patent/CA2516652A1/fr not_active Abandoned
- 2004-02-24 EP EP04775799A patent/EP1597354A4/fr not_active Withdrawn
- 2004-02-24 WO PCT/US2004/005518 patent/WO2005007832A2/fr active Application Filing
- 2004-02-24 JP JP2006532296A patent/JP2007500012A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2007500012A (ja) | 2007-01-11 |
WO2005007832A2 (fr) | 2005-01-27 |
EP1597354A2 (fr) | 2005-11-23 |
EP1597354A4 (fr) | 2008-07-02 |
WO2005007832A3 (fr) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6676935B2 (en) | Tissue specific adenoviral vectors | |
US6432700B1 (en) | Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same | |
AU744725B2 (en) | Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same | |
CA2343135C (fr) | Vecteurs d'adenovirus contenant des elements de reponse specifiques de l'etat des cellules, et procedes d'utilisation desdits vecteurs | |
US6495130B1 (en) | Target cell-specific adenoviral vectors containing E3 and methods of use thereof | |
WO1998039464A9 (fr) | Vecteurs d'adenovirus contenant des elements heterologues regulateurs de transcription, et leur procede d'utilisation | |
US6692736B2 (en) | Cell-specific adenovirus vectors comprising an internal ribosome entry site | |
AU745560B2 (en) | Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof | |
US6197293B1 (en) | Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof | |
US20030152553A1 (en) | Compositions comprising tissue specific adenoviral vectors | |
US7276233B2 (en) | Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy | |
WO1998039467A2 (fr) | Vecteurs d'adenovirus specifiques de cellules exprimant l'antigene carcino-embrionnaire et leurs methodes d'utilisation | |
AU2001247648B2 (en) | Cell-specific adenovirus vectors comprising an internal ribosome entry site | |
AU2001247648A1 (en) | Cell-specific adenovirus vectors comprising an internal ribosome entry site | |
AU2001243704B2 (en) | Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation | |
CA2516652A1 (fr) | Systeme pour la commande externe de la reproduction d'un virus oncolytique | |
AU2001243704A1 (en) | Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation | |
US20040241857A1 (en) | Tissue specific adenoviral vectors | |
EP1905837A1 (fr) | Vecteurs d'adénovirus contenant des éléments hétérologues régulateurs de la transcription et procédés les utilisant | |
AU6445698A (en) | Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof | |
EP0968298A2 (fr) | Vecteurs d'adenovirus specifiques de cellules exprimant l'antigene carcino-embrionnaire et leurs methodes d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |